Heparin-induced thrombocytopenia and cardiovascular diseases

Am Heart J. 2006 Jul;152(1):19-26. doi: 10.1016/j.ahj.2005.10.005.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Arginine / analogs & derivatives
  • Cardiac Surgical Procedures
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / physiopathology
  • Cardiovascular Diseases* / therapy
  • Chondroitin Sulfates / therapeutic use
  • Dermatan Sulfate / therapeutic use
  • Diagnosis, Differential
  • Fondaparinux
  • Heparin / adverse effects*
  • Heparitin Sulfate / therapeutic use
  • Hirudins
  • Humans
  • Peptide Fragments / therapeutic use
  • Pipecolic Acids / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Factor 4 / immunology
  • Platelet Factor 4 / physiology
  • Polysaccharides / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Sensitivity and Specificity
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / complications
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / epidemiology
  • Thrombosis / etiology

Substances

  • Anticoagulants
  • Hirudins
  • Peptide Fragments
  • Pipecolic Acids
  • Platelet Aggregation Inhibitors
  • Polysaccharides
  • Recombinant Proteins
  • Sulfonamides
  • Dermatan Sulfate
  • Platelet Factor 4
  • Heparin
  • Chondroitin Sulfates
  • Heparitin Sulfate
  • Arginine
  • danaparoid
  • argatroban
  • Fondaparinux
  • bivalirudin